NCT01887574

Brief Summary

Collect valuable risk factor and quality of life data from Renal Cell Carcinoma patients and harness the latest technology to organize and analyze data.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
141

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2013

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

June 5, 2013

Completed
22 days until next milestone

First Posted

Study publicly available on registry

June 27, 2013

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 12, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 12, 2017

Completed
Last Updated

June 17, 2020

Status Verified

June 1, 2020

Enrollment Period

3.9 years

First QC Date

June 5, 2013

Last Update Submit

June 15, 2020

Conditions

Renal Cell Carcinoma

Outcome Measures

Primary Outcomes (1)

  • Evidence of Renal Mass Risk Factors as determined by patient questionnaire post surgery

    5 years

Study Arms (1)

Open

EXPERIMENTAL
Other: questionnaire

Interventions

questionnaireOTHER

questionnaires given to all patients to assess risk factors and quality of life

Open

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with a renal mass or a suspected metastatic lesion from a renal primary who have been treated or are going to be studied and or treated surgically at Mayo Clinic Arizona
  • Patients must be 18 years of age or older
  • Patients must be capable of and willing to sign an informed consent

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic in Arizona

Scottsdale, Arizona, 85259, United States

Location

Related Links

MeSH Terms

Conditions

Carcinoma, Renal Cell

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

AdenocarcinomaCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasmsKidney NeoplasmsUrologic NeoplasmsUrogenital NeoplasmsNeoplasms by SiteFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesKidney DiseasesUrologic DiseasesMale Urogenital Diseases

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Erik Castle, MD

    Mayo Clinic

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 5, 2013

First Posted

June 27, 2013

Study Start

June 1, 2013

Primary Completion

April 12, 2017

Study Completion

April 12, 2017

Last Updated

June 17, 2020

Record last verified: 2020-06

Locations

US(1)